Finn Stockinger
Equity Analyst & Investor, Technology Research
Xanadu's stock was a textbook trap that has now sprung, falling about 60% premarket as insiders exit. An S-1 registered about 294M shares for resale by existing holders, which brings the company nothing and floods the float of a startup with $4.6M in annual revenue. A multi-billion-dollar valuation was unsustainable, and as a post-SPAC name its hype premium evaporated once lockups and conversions hit. Brilliant technology doesn't make a safe stock when insiders rush for the exits. x.com
Xanadu at $15 is a textbook FOMO trap and too early to buy after a nearly 85% rally from recent lows. A price-to-sales ratio in the hundreds pays today for success scheduled five years out: 2025 revenue was $4.6M, 2026 is forecast at $15-20M, and positive cash flow is targeted only by 2029-2030. It must cut chip optical losses roughly 20-30x, and the insider lock-up ends in September 2026. The photonic quantum technology is a masterpiece; better to wait for a correction. x.com x.com
Xanadu Quantum Technologies' lofty valuation came from linking itself to the hot photonics sector, and in hindsight the push may have been meant to lift the stock as high as possible before selling. A post the author replies to adds that a short float drove the stock far past its fundamental value, and float mechanics did play a role. x.com
XNDU's setup changes now that its 27.5M-share PIPE has been registered as of this morning, with those PIPE shares coming into today up 350%. x.com x.com
Xanadu and Infleqtion are the most interesting and least scammy public quantum stocks, and this is a time to look at speculative names rather than safety trades. Xanadu completed its de-SPAC last week, removing that risk, and fell 14% to below its $10 conversion price. Quantum is unlikely to be winner-take-most since modalities have different advantages, though in photonics PsiQuantum has far more money and bigger backers than Xanadu. x.com x.com
T1 Energy remains unattractive because, as an unprofitable business, it faces high dilution risk, substantial stock-based compensation, reliance on unlikely future promises and valuation that becomes difficult in a panic. x.com
WFF's $612.4 million valuation looks vulnerable after its 559% surge: recent F-3 and 424B5 filings pose dilution risk. x.com
D-Wave Quantum is hard to justify as a $7B company trading at 50x 2028 sales in a highly speculative industry, and its CFO is resigning. x.com
Applied Optoelectronics is diluting shareholders with a $600M offering, which sent the stock down 9% after hours. Management likes to burn shareholders, so staying away for now. x.com x.com x.com
Quanome Technologies' 124% gap up on its AI and quantum story looks set to fade, with a $1.00 target. With a $49M market cap, a 25.8M-share float and only 4.7% short interest, the large float and low short interest make for a weak squeeze setup. Insider selling is likely on a big gap, and S-3 filings could bring dilution. x.com
SpaceX shares face more selling pressure because shareholder unlocks haven't even happened yet. Insiders have waited 10–20 years to exit. Facebook's 2012 IPO is the parallel: it opened at $38, fell to $18 and stayed underwater for over a year, recovering only after lockups ended and insiders exited. With only 5% of SpaceX stock available to trade, 30% short interest is almost meaningless. x.com x.com
Fluence faces a material short-term overhang after management made about 117.7 million shares eligible for shelf-registered resale. The 20 million-share offering is an unlock and transfer, not dilution, but it leaves roughly 97 million more shares able to be sold, expanding the float and adding selling pressure. That creates a heavy psychological overhang even if nothing is sold; left alone, the stock could easily have doubled. The pending hyperscaler deals are what to watch. x.com x.com
